Sandhya Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandhya Sharma has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Waseem Asghar
Asghar-Lab, Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA
2 shared publications Alamgir Kabir
From the Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton
1 shared publication- Alamgir Kabir
Asghar-Lab, Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Boca Raton, FL 33431, USA
1 shared publication Azhar Ilyas
Department of Electrical & Computer Engineering, New York Institute of Technology, Old Westbury, NY 11568, USA
1 shared publicationMariano A. Garcia-Blanco
Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
1 shared publicationMarisa Long
Asghar-Lab, Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Boca Raton, FL 33431, USA
1 shared publication
Latest Publications
- 11 August 2020
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 144 (11) , 1335-1343
Lab-on-a-Chip Zika Detection With Reverse Transcription Loop-Mediated Isothermal Amplification–Based Assay for Point-of-Care Settings
Context.—: Zika virus (ZIKV) infection, primarily transmitted by mosquitoes, causes various neurologic disorders. To differentiate ZIKV from other arboviruses, such as dengue, chikungunya, and yellow fever viruses, a highly specific, sensitive, and automated detection system is needed for point-of-care (POC) settings. Objective.—: To detect ZIKV at POC settings, we have developed a fully automated lab-on-a-chip microfluidic platform for rapid disease detection by using reverse transcription loop–mediated isothermal amplification. Design.—: The developed setup consists of a microfluidic chip, a platform for magnetic actuation, and a heater along with the sensor to precisely control the temperature for the target amplification. The platform accurately controls the movement of the magnetic beads that enable the isolation and purification of the target nucleotides adhered to their surface for the amplification and disease detection on the microfluidic chip. Results.—: Within 40 minutes, change in color due to the presence of ZIKV amplicons was visually observed with the spiked plasma samples in the end point analysis. Also, we have accurately and specifically identified ZIKV in a small number of de-identified clinical samples. Conclusions.—: All-inclusive, the developed fully automated POC ZIKV diagnostic chip is rapid, simple, easy to use, inexpensive, and suitable for the areas where facilities are limited.
- 11 August 2020
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 144 (11) , 1335-1343
Lab-on-a-Chip Zika Detection With Reverse Transcription Loop-Mediated Isothermal Amplification–Based Assay for Point-of-Care Settings
Context.—: Zika virus (ZIKV) infection, primarily transmitted by mosquitoes, causes various neurologic disorders. To differentiate ZIKV from other arboviruses, such as dengue, chikungunya, and yellow fever viruses, a highly specific, sensitive, and automated detection system is needed for point-of-care (POC) settings. Objective.—: To detect ZIKV at POC settings, we have developed a fully automated lab-on-a-chip microfluidic platform for rapid disease detection by using reverse transcription loop–mediated isothermal amplification. Design.—: The developed setup consists of a microfluidic chip, a platform for magnetic actuation, and a heater along with the sensor to precisely control the temperature for the target amplification. The platform accurately controls the movement of the magnetic beads that enable the isolation and purification of the target nucleotides adhered to their surface for the amplification and disease detection on the microfluidic chip. Results.—: Within 40 minutes, change in color due to the presence of ZIKV amplicons was visually observed with the spiked plasma samples in the end point analysis. Also, we have accurately and specifically identified ZIKV in a small number of de-identified clinical samples. Conclusions.—: All-inclusive, the developed fully automated POC ZIKV diagnostic chip is rapid, simple, easy to use, inexpensive, and suitable for the areas where facilities are limited.
- Open Access
- 17 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
An antibody panel for highly specific detection and differentiation of Zika virus
Zika virus (ZIKV) is an emerging flavivirus transmitted to humans by Aedes mosquitos. ZIKV can be transmitted from mother to fetus during pregnancy and can cause microcephaly and other birth defects. Effective vaccines for Zika are yet to be approved. Detection of the ZIKV is based on serological testing that often shows cross-reactivity with the Dengue virus (DENV) and other flaviviruses. We aimed to assemble a highly specific anti-Zika antibody panel to be utilized in the development of a highly specific and cost-effective ZIKV rapid quantification assay for viral load monitoring at point-of-care settings. To this end, we tested the affinity and specificity of twenty one commercially available monoclonal and polyclonal antibodies against ZIKV and DENV envelope proteins utilizing nine ZIKV and twelve DENV strains. We finalized and tested a panel of five antibodies for the specific detection and differentiation of ZIKV and DENV infected samples.
- 17 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Open AccessAn antibody panel for highly specific detection and differentiation of Zika virus
Zika virus (ZIKV) is an emerging flavivirus transmitted to humans by Aedes mosquitos. ZIKV can be transmitted from mother to fetus during pregnancy and can cause microcephaly and other birth defects. Effective vaccines for Zika are yet to be approved. Detection of the ZIKV is based on serological testing that often shows cross-reactivity with the Dengue virus (DENV) and other flaviviruses. We aimed to assemble a highly specific anti-Zika antibody panel to be utilized in the development of a highly specific and cost-effective ZIKV rapid quantification assay for viral load monitoring at point-of-care settings. To this end, we tested the affinity and specificity of twenty one commercially available monoclonal and polyclonal antibodies against ZIKV and DENV envelope proteins utilizing nine ZIKV and twelve DENV strains. We finalized and tested a panel of five antibodies for the specific detection and differentiation of ZIKV and DENV infected samples.
- 1 July 2018
- Published by Elsevier in Biotechnology Advances
- Vol. 36 (4) , 1063-1078
Circulating tumor cell isolation, culture, and downstream molecular analysis
- 1 July 2018
- Published by Elsevier in Biotechnology Advances
- Vol. 36 (4) , 1063-1078
Circulating tumor cell isolation, culture, and downstream molecular analysis